Breaking AI & Tech News Analyzed

Fresh Israeli airstrikes have struck southern Lebanon, resulting in multiple fatalities and injuries, just a day after a devastating attack that claimed over 200 lives. The escalation has sparked concerns about the stability of the recently announced US-Iran ceasefire, which Tehran says includes Lebanon.Lebanon's National News Agency reported that an Israeli strike on the town of Abbassiyeh killed at least seven people and wounded several others, with the total expected to rise. The attacks have targeted various towns, including Kafra, Jmaijmeh, Safad al-Battikh, Majdal Selm, and Deir Antar near Qasmiyeh bridge.The Lebanese army confirmed that four of its soldiers were killed in Israeli strikes on Wednesday. The Israeli military claimed that it carried out overnight strikes in Beirut, killing Ali Yusuf Harshi, a close aide to Hezbollah leader Naim Qassem.The scale and intensity of the attacks suggest a broader campaign that continues despite the ceasefire agreement. Al Jazeera's Nida Ibrahim reported from Ramallah that the ongoing strikes reflect a deeper alignment between Israel and the US. Hezbollah has insisted that the ceasefire deal between the US and Iran should include the Lebanon front.According to the Lebanese health ministry, 203 people were killed on Wednesday, with over 1,000 wounded in Israeli attacks across Lebanon. Lebanon's prime minister declared a national day of mourning on Thursday, ordering public offices to close and flags to be lowered in tribute.International leaders have condemned the attacks, with UN human rights chief Volker Turk describing the scale of killing as 'horrific'. French Foreign Minister Jean-Noel Barrot said: 'We strongly condemn these massive strikes which, in ten minutes, killed more than 250 people, adding to the 1,500 victims of this conflict initiated by Hezbollah against Israel on March 2.'Lebanon's Health Ministry reports that Israeli attacks since March 2 have killed at least 1,739 people and wounded 5,873 people.

The conflict in Gaza has resulted in a significant number of amputations, with over 6,000 adults and children undergoing amputations since October 2023, according to the WHO and Palestinian Ministry of Health. Ola Jamal, 36, is one of the many Palestinians who have been forced to flee Gaza due to the conflict. She was breastfeeding her two-month-old son, Zain, when a missile struck al-Nasr hospital in Gaza, causing her to lose her arm. Jamal and her family were forced to separate, with her children being cared for by another family. This traumatic experience has had a lasting impact on Jamal and her children, with her son Zain still experiencing nightmares and trauma two years after the event. Shadi Sharif Ayesh al-Sous, a father of two, lost his leg in a missile strike while collecting firewood. He had his leg amputated above the knee and now waits to return home to Gaza. However, many Palestinians in Egypt face significant challenges, including restricted access to healthcare and prosthetic care due to their uncertain legal status. Yousef El Deeb, a certified prosthetist at Orthomedics in Cairo, says his clinic has treated about 300 Palestinian patients since October 2023, mostly through the support of NGOs. However, the lack of documentation and uncertain legal status of Palestinians in Egypt makes it difficult for them to access long-term prosthetic care without the support of NGOs. The situation for Palestinians in Egypt is further complicated by their lack of formal residency or refugee status. Without valid residency permits, survivors are often restricted to hostels or share a flat with other families, unable to work and living under the constant pressure of temporary status. This lack of documentation makes accessing hi-tech, long-term prosthetic care almost impossible without the support of NGOs.

Gentleman's Relish, a traditional British condiment, has been discontinued by its manufacturer, AB World Foods. However, Simpson's restaurant in London and Fortnum & Mason have stepped in to keep the spread alive. Jeremy King, who reopened Simpson's in the Strand last month, has instructed his chef to create a version of Gentleman's Relish almost identical to the original.The relish, made from anchovy fillets, rusk, butter, and a secret selection of herbs and spices, was created by John Osborn in 1828. It was a favourite condiment of James Bond writer Ian Fleming and has been named as one of the 10 foods that Nigella Lawson cannot live without. Simpson's serves the relish on toast for £6.50, while Fortnum & Mason offers it in a Tiffany blue pot for £14.95.King's version of the relish is based on a classic Victorian recipe for patum peperium, which he prefers to the mass-produced version. While he would like to sell it as a takeaway product, health and safety regulations prevent this. Nigella Lawson has expressed her love for the relish, saying it's a savoury version of cinnamon toast and just as comforting.

Meta announced the launch of Muse Spark, the debut artificial‑intelligence model from the company’s ambitious "superintelligence" squad that was assembled last year with a multi‑billion‑dollar budget. The team, spearheaded by former Scale AI chief Alex Wang—brought on board in a $14.3 bn acquisition—has been offered compensation packages running into the hundreds of millions to attract top talent. Muse Spark is the first installment of the internally codenamed "Avocado" series. For now, the model is accessible only through Meta’s AI app and website, but Meta says it will soon supplant the existing Llama models that power chatbots on WhatsApp, Instagram, Facebook and the firm’s smart‑glasses lineup. Unlike earlier open releases of Llama, Meta has kept Muse Spark’s architecture details under wraps, offering a private preview to a select group of unnamed partners. In a blog post, Meta described the system as "small and fast by design, yet capable enough to reason through complex questions in science, math and health," positioning it as a solid foundation for future, larger versions. Independent testing shows Muse Spark narrowing the gap with leading models from Google, OpenAI and Anthropic in language and visual comprehension, though it still trails in coding and abstract reasoning tasks. The model placed tied for fourth on a comprehensive AI benchmark compiled by Artificial Analysis. CEO Mark Zuckerberg had previously cautioned investors that early releases would be modest but would demonstrate a "rapid trajectory." Wang echoed this sentiment on social media, acknowledging "rough edges" that will be refined over time and confirming that bigger variants are already in development, with some slated for open release. Beyond performance metrics, Meta hinted at commercial ambitions, embedding shopping suggestions directly into its AI chatbot to guide users toward purchasable items. With over 3.5 billion active users across its platforms, the company hopes AI‑driven personal tasks will boost engagement and create a competitive edge over rivals with smaller user bases. Practical use‑cases highlighted include estimating meal calories from a photo, virtually placing a mug on a shelf via augmented reality, and a new "Contemplating Mode" that runs multiple agents simultaneously—mirroring advanced reasoning features seen in Google’s Gemini Deep Think and OpenAI’s GPT‑Pro. Meta says this mode could, for example, help a family plan a vacation by having one agent draft an itinerary while another scouts kid‑friendly activities.

A 47‑year‑old woman who had endured three life‑threatening autoimmune diseases for more than a decade is now living a near‑normal life after an experimental CAR‑T cell therapy reset her immune system at University Hospital Erlangen in Germany.Before the procedure she had exhausted nine different treatments with no lasting benefit, relying on daily blood transfusions and continuous anticoagulation to manage her illnesses.Within weeks of the infusion, doctors observed rapid improvement in all three conditions—a world‑first outcome. She has remained in treatment‑free remission for 14 months and has largely returned to everyday activities.Prof Fabian Müller, who led the team, called the speed and depth of the response “remarkable” and said the therapy “significantly improved her quality of life.” He emphasized that clinical trials are required to determine how durable the effect is and whether it can help other autoimmune patients.The patient suffered from three distinct disorders: autoimmune haemolytic anaemia (AIHA), where rogue immune cells destroy red blood cells; immune thrombocytopenia (ITP), which depletes platelets and raises bleeding risk; and antiphospholipid syndrome (APS), which promotes dangerous blood clots. All three stem from malfunctioning B‑cells.With no conventional options left, doctors turned to CAR‑T therapy, a technique that has revolutionised treatment for certain cancers. They harvested her white‑blood cells, isolated the T‑cells, engineered them to recognise the CD19 protein on B‑cells, and reinfused the modified cells.The engineered T‑cells swiftly eliminated the pathogenic B‑cells. She received her last blood transfusion a week after treatment and was able to perform routine tasks within two weeks. Follow‑up tests showed a reconstituted, healthy B‑cell population, suggesting an immune reset. The findings were published in the journal Med.She still exhibits a mildly low white‑cell count and slightly elevated liver enzymes, which researchers attribute to the cumulative impact of prior therapies rather than the CAR‑T product.Rheumatology expert Prof Ben Parker of Manchester University NHS Foundation Trust described the case as encouraging, noting that “the prolonged response off normal therapy suggests there has been an immune reset.” However, he warned that case reports alone cannot confirm efficacy and highlighted ongoing trials for lupus, myositis, multiple sclerosis, systemic sclerosis, vasculitis, and other autoimmune conditions.

Oil tanker workers stuck in the Gulf for six weeks are reaching their limit, with mental health concerns escalating due to the prolonged standoff. A crew member, who spoke to the Guardian, revealed that the situation is becoming increasingly unbearable.The worker, one of 20,000 seafarers trapped by Iran's chokehold on the Strait of Hormuz, expressed frustration and despair, stating that any hope of being freed had evaporated. The crew member's tanker is anchored near dozens of loaded tankers, with many feeling unwilling and unable to traverse the strait, even if a ceasefire allowed them to do so.90% of the crew on the tanker want to exercise their right to refuse to sail, citing safety concerns. The situation has taken a toll on the crew's mental health, with one member suffering a 'mental breakdown' and being checked on regularly by colleagues.The International Transport Workers' Federation (ITF) has received about 1,000 inquiries from seafarers on 300 different vessels, with 20% seeking repatriation. The union and other organizations are trying to provide support, but the situation remains dire.The shipping companies are expected to find new crew members willing to work in hazardous areas, offering double pay and promotions. However, the workers stuck on the tankers hope that their vessel will be taken to anchorage to allow new crew to take their places.The situation has reignited calls for shipowners to replace their crews with mariners willing to offer relief, highlighting the human cost of the conflict.

The UK government's spending on foreign aid has hit its lowest level in nearly two decades, with provisional data showing 0.43% of national income allocated to official development assistance (ODA) in 2025, down from 0.5% in 2024 and matching the level in 2008. The total ODA spend in 2025 was just over £13bn, an annual decrease of £1bn, or 7.4%. This decline has raised alarms among humanitarian experts, who warn that the cuts are having severe consequences, particularly for marginalized communities across Africa. Gideon Rabinowitz, director of policy and advocacy at Bond, emphasized that life-saving humanitarian programs, including education provision in Syria and healthcare programs across Africa, have already been forced to close. He warned that with even deeper cuts expected, the worst consequences are yet to be realized. The Organisation for Economic Cooperation and Development (OECD) noted that a projected 9% to 17% drop of ODA among its members in 2025 would hit the poorest countries hardest. The UK's reduction in aid spending has been criticized by campaigners and aid organizers, who argue it will cause widespread damage and weaken the UK's influence overseas. In response, the Foreign, Commonwealth and Development Office stated that national security is the government's first duty and that the decision to reduce ODA spending to 0.3% of GNI by 2027 was necessary to fund an increase in defense spending. However, they emphasized that the UK remains committed to safeguarding standards and protecting women and girls.

Federal weather data reveal that March 2026 was the hottest March ever recorded across the continental United States in a 132‑year dataset, with average temperatures soaring to 50.85 °F (10.47 °C), a staggering 9.35 °F (5.19 °C) above the 20th‑century March norm. This anomaly eclipsed the previous record of an 8.9 °F excess set in March 2012, marking the most extreme departure from average temperatures for any month in U.S. history. The month’s daytime highs were equally extreme, averaging 11.4 °F above the long‑term benchmark—almost a degree hotter than the typical April high, according to the National Oceanic and Atmospheric Administration (NOAA). Such extreme warmth is part of a broader trend: six of the ten most abnormal heat months have occurred within the last decade, and February 2026, at 6.57 °F above normal, ranked as the tenth most anomalous month on record. “The March heat wave was unprecedented across the United States,” noted Shel Winkley of Climate Central, emphasizing the sheer volume of records broken. In just two days (March 20‑21), roughly one‑third of the nation experienced temperatures that would have been virtually impossible without human‑induced climate change, according to Climate Central’s analysis. Data compiled by meteorologist Guy Walton shows that more than 19,800 daily temperature records were surpassed in March, and over 2,000 locations set new monthly heat records—a volume of record‑breaking events usually spread across entire decades. Jeff Masters of Yale Climate Connections warned that “climate change is kicking our butts,” adding that the January‑March period was the driest on record for the contiguous United States. The combination of extreme heat and historic dryness threatens water supplies, agriculture, river navigation, and overall ecosystem health. Looking ahead, both the European Copernicus climate service and NOAA project the formation of a “super” El Niño in the coming months, with the potential to amplify global temperatures into late 2026 and 2027. Meteorology professor Victor Gensini of Northern Illinois University cautioned that such an event could push the planet to new record‑high temperature thresholds.

As rising temperatures push snakes and humans into closer contact, the world faces an estimated 5.5 million snakebites each year, resulting in 138,000 deaths and 400,000 lasting disabilities. In response, a Wisconsin‑based amateur scientist has taken an extreme route to help solve the crisis.For almost 20 years, Tim Friede, a former window cleaner, allowed some of the planet’s most lethal snakes to bite him, accumulating over 200 intentional bites. His goal: to provoke his own immune system into producing antibodies that could be harvested for a near‑universal antivenom.The endeavor has been perilous. Friede survived a coma after being bitten by two cobras within an hour, endured anaphylactic shocks, lost tissue in a finger, and even had to cut necrotic muscle from his leg. Yet he persisted, eventually becoming immune to the inland taipan—the world’s most venomous snake, whose single bite can kill more than 100 people.In 2019, California biotech firm Centivax hired Friede to extract his antibodies. Early laboratory work showed that his serum can neutralise toxins from 19 elapid species, including cobras, mambas, taipans, coral snakes and kraits—roughly half of all venomous snakes worldwide.The next step is a veterinary trial in Australia, slated for later this year, before any human application. If successful, the antivenom could dramatically reduce the burden of snakebite in low‑income regions across Asia and Africa, where most victims live.Climate scientists warn that warming climates will expand snake habitats and increase human exposure, as illustrated by the recent surge of rattlesnake bites in California’s Ventura County. This amplifies the urgency for scalable, affordable antivenoms, especially as international aid budgets face cuts and manufacturing capacity remains insufficient.Friede’s unconventional path underscores a broader lesson: confronting emerging health threats may require bold, unconventional science, but the potential payoff—a life‑saving treatment for millions—could be transformative.